Icatibant Outcome Survey – Prof. Marcus Maurer

Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals

212

Hernández Fernández de Rojas, D.+, Ibáňez, E., Longhurst, H., Maurer, M. Fabien, V., Aberer, W., Bouillet, L., Zanichelli, A., and Caballero, T.: Treatment of HAE attacks in the icatibant outcome survey: an analysis of icatibant self-administration versus administration by health care professionals. Int. Arch. Allergy Immunol. 2015: 167; 21-28. IF: 2.67

Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey

340

Maurer, M.+, Bork, K., Martinez-Saguer, I., Aygören-Pürsün, E., Botha, J., Andresen, I., and Magerl, M.: Management of patients with hereditary angioedema in Germany: comparison to other countries in the icatibant outcome survey. J. Eur. Acad. Dermatol. Venereol. 2019: 33; 163-169. IF: TBD (IF 2018: 5.11)

Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey

359

Bygum, A.+, Caballero, T., Grumach, A. S., Longhurst, H. J., Bouillet, L., Aberer, W., Zanichelli, A., Botha, J., Andresen, I., Maurer, M. for the IOS study group: Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the icatibant outcome survey. Clin. Transl. Allergy 2019: 9; 37. IF: 5.13

o.359